Purpose

The primary aim of this observational registry is to study the outcomes of patients with hemorrhagic shock transported by Boston MedFlight receiving blood products during transport.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult patients who would be eligible to receive blood products; - systolic blood pressure <90 mmHg - a shock index of > 0.9 - clinical signs of shock as determined by the transport clinicians.

Exclusion Criteria

  • Age < 18 years old

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Blood products during transport Administration of appropriate blood products during transport
Standard of Care Receiving standard prehospital air medical care

Recruiting Locations

Massachusetts General Hospital
Boston, Massachusetts 02114
Contact:
Susan R Wilcox, MD
617-724-1973
SWILCOX1@PARTNERS.ORG

More Details

Status
Recruiting
Sponsor
Massachusetts General Hospital

Study Contact

Kerry Breen
617-643-2440
KBREEN6@MGH.HARVARD.EDU

Detailed Description

Boston MedFlight, a critical care transport organization, based on a consortium of the academic medical centers in Boston, will begin carrying PRBC in 2019. The program is intended to provide BMF clinicians with 24-hour immediate access to appropriate blood products to be utilized if needed for patients following life-threatening illness or injury. The four fundamental goals of this program are: save lives' ensure transfusion safety; minimize blood product waste; and conduct continuous quality assurance. Our goal is to observationally evaluate this new protocol of administering blood products in the pre-hospital setting. We will collect data on patients with hemorrhagic shock being transported by Boston MedFlight, who receive or would have been eligible to receive pre-hospital blood transfusion by the inclusion criteria.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.